Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Apotex Corp.Recalls Single Lot of Carbamazepine Tablets 200 mg
Apotex Corp. has recalled a single lot of Carbamazepine Tablets 200 mg. Lot number JD2135 has been recalled because routine testing found that tablets in this lot may contain impurities. Carbamazepine is used in the treatment of epilepsy and trigeminal neuralgia. It is also sometimes used to treat mania, bipolar disorder, and other mood disorders. Carbamazepine is also sold under several different brand names. This recall alert only applies to the single lot of the generic Carbamazepine Tablets 200 mg made by Apotex. No other Carbamazepine products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm220487.htm
Learn More

FDA Stops Imports of Ranbaxy Products
The U.S. Food and Drug Administration (FDA) is stopping the importation of several drug products produced by the generic drug manufacturer Ranbaxy Laboratories, Ltd.  The FDA is concerned that Ranbaxy facilities in India are not following U.S. standards for good manufacturing practices.  Although carbidopa/levodopa is one of the medications manufactured by Ranbaxy, drug shortages are not expected because, in most instances, there are enough other suppliers that can help meet demand for carbidopa/levodopa. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116949.htm
Learn More

Date Published Title Drug Source
2010-07-30 Apotex Corp.Recalls Single Lot of Carbamazepine Tablets 200 mg Carbamazepine FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Carbidopa / Levodopa FDA
2008-08-04 Generic Manufacturer Recalls Several Drug Products Carisoprodol Manufacturer
2008-08-05 Generic Manufacturer Recalls Several Drug Products Carisoprodol with Aspirin Manufacturer
2009-05-04 New FDA Labeling for OTC Pain Relievers Also Applies to Patients Taking Combination Products Carisoprodol with Aspirin FDA
2011-01-10 Sandoz Inc. Recalls Single Lot of Carvedilol Tablets Carvedilol FDA
2011-04-25 Teva Pharmaceuticals Recalls Single Lot of Carvedilol Tablets, 12.5 mg Carvedilol FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Cefaclor FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Cefadroxil FDA
2007-11-14 Early Communication about an Ongoing Safety Review Cefepime FDA
2009-06-17 FDA Update on Ongoing Safety Review of Cefepime (Maxipime) Cefepime FDA
2012-06-26 FDA Warns Cefepime Needs Dosage Reduced in Patients with Poor Kidney Function Cefepime FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Cefpodoxime FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Cefprozil FDA
2012-03-07 Sandoz Inc. Recalls Select Lots of Cefprozil Powder for Oral Suspension, USP 125 mg/5 mL and 250 mg/5 mL Cefprozil FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Cefuroxime FDA
2008-08-13 Heart risks associated with celecoxib (Celebrex) Celecoxib MediGuard CRT
2011-12-22 Eclectic Institute Recall Specific Dietary Supplements Containing Gotu Kola (Centella Asiatica) And Bladderwrack (Fucus Vesiculosus) Due to Possible Bacteria Contamination FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Cephalexin FDA
2008-06-04 Early communication regarding cancer link in children Certolizumab FDA
Back to Consumer Med Safety